- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Gufic Biosciences reported revenue growth with improving margins, driven by product portfolio expansion and operational efficiencies. Management highlighted strong order inflows and a solid market position, underscoring confidence in sustained business momentum and growth prospects.